Quanterix Corporation Total Assets 2011-2026 | QTRX

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Quanterix Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
419 M	407 M	425 M	434 M	502 M	271 M	170 M	67.6 M	91.8 M	37.1 M	7.35 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
502 M	7.35 M	257 M

Quarterly Total Assets Quanterix Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
444 M	376 M	397 M	407 M	-	411 M	412 M	425 M	429 M	427 M	434 M	447 M	489 M	505 M	502 M	511 M	528 M	533 M	271 M	271 M	271 M	271 M	170 M	170 M	170 M	170 M	67.6 M	67.6 M	67.6 M	67.6 M	91.8 M	91.8 M	91.8 M	91.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
533 M	67.6 M	305 M

Total Assets of other stocks in the Medical devices industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
BioSig Technologies BSGM	842 K	-	37.08 %	$ 85.7 M	USA
GenMark Diagnostics, Inc. GNMK	224 M	-	-	$ 1.77 B	USA
Beyond Air XAIR	30.1 M	$ 0.72	3.86 %	$ 48.7 M	USA
Axonics Modulation Technologies AXNX	659 M	-	-	$ 3.31 B	USA
Dynatronics Corporation DYNT	15.4 M	-	14.99 %	$ 929 K	USA
Aziyo Biologics AZYO	62.4 M	-	1.37 %	$ 20.5 M	USA
Acutus Medical AFIB	54 M	-	-26.83 %	$ 2.62 M	USA
Xtant Medical Holdings XTNT	93.8 M	$ 0.54	-4.43 %	$ 72.2 M	USA
Zimmer Biomet Holdings ZBH	21.4 B	$ 88.29	-0.97 %	$ 17.9 B	USA
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
Align Technology ALGN	6.21 B	$ 165.93	-6.43 %	$ 12.4 B	USA
Obalon Therapeutics, Inc. OBLN	10.6 M	-	-5.86 %	$ 30.6 M	USA
Alphatec Holdings ATEC	791 M	$ 10.9	-5.43 %	$ 1.64 B	USA
Conformis CFMS	94 M	-	-	$ 16.4 M	USA
Accuray Incorporated ARAY	470 M	$ 0.39	4.51 %	$ 40.1 M	USA
Abbott Laboratories ABT	86.7 B	$ 104.33	-0.23 %	$ 182 B	USA
Cardiovascular Systems CSII	323 M	-	0.15 %	$ 844 M	USA
Second Sight Medical Products EYES	39.4 M	-	-0.97 %	$ 54.4 M	USA
Apollo Endosurgery APEN	110 M	-	-	$ 475 M	USA
Boston Scientific Corporation BSX	43.7 B	$ 69.42	-1.07 %	$ 103 B	USA
Avinger AVGR	13.8 M	-	-20.74 %	$ 369 K	USA
CryoLife, Inc. CRY	789 M	-	-4.14 %	$ 702 M	USA
CONMED Corporation CNMD	2.33 B	$ 34.68	-5.35 %	$ 1.08 B	USA
Soliton, Inc. SOLY	33.8 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	10.5 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	64.1 M	-	0.03 %	$ 1.58 B	Israel
NanoVibronix NAOV	3.63 M	-	-	$ 1.08 M	USA
Misonix, Inc. MSON	204 M	-	-	$ 462 M	USA
Neovasc NVCN	66.2 M	-	-	$ 111 M	Canada
Intersect ENT, Inc. XENT	227 M	-	-	$ 955 M	USA
Cytosorbents Corporation CTSO	47.4 M	$ 0.6	-0.18 %	$ 32.7 M	USA
Aethlon Medical AEMD	7.36 M	$ 2.14	-5.73 %	$ 3.34 M	USA
Edwards Lifesciences Corporation EW	13.7 B	$ 79.45	-3.23 %	$ 46.5 B	USA
BIOLASE BIOL	35.1 M	-	-13.19 %	$ 166 K	USA
AdaptHealth Corp. AHCO	4.32 B	$ 11.11	-2.63 %	$ 1.5 B	USA
OrthoPediatrics Corp. KIDS	509 M	$ 15.65	-4.31 %	$ 367 M	USA
Invacare Corporation IVC	771 M	-	-	$ 24.7 M	USA
Ra Medical Systems RMED	16.8 M	-	10.0 %	$ 610 K	USA
Myomo MYO	38.6 M	$ 0.67	-1.26 %	$ 28 M	USA
Penumbra PEN	1.83 B	$ 335.28	-0.34 %	$ 13 B	USA
Inspire Medical Systems INSP	907 M	$ 49.77	-1.35 %	$ 1.46 B	USA
Pulmonx Corporation LUNG	129 M	$ 1.17	-5.65 %	$ 47.6 M	USA
Cutera CUTR	346 M	-	-10.19 %	$ 1.99 M	USA
Eargo EAR	132 M	-	-	$ 10.2 M	USA
NuVasive NUVA	2.22 B	-	-	$ 2.07 B	USA
Nevro Corp. NVRO	554 M	-	-	$ 217 M	USA
Surgalign Holdings SRGA	70.2 M	-	-32.98 %	$ 1.68 M	USA
STRATA Skin Sciences SSKN	52.3 M	-	-	$ 6.6 M	USA